FGF-2 promotes ESCC cell metastasis and stimulates endothelial cell production by binding to the FGFR-1 receptor and activating the PI3K-AKT and ERK1/2 signaling pathways (79). The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.